1-3 of 3
Lucy C. Pemberton
Close
Sort by
Journal Articles

A gene expression signature of CD34 + cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib

Shannon K. McWeeney, Lucy C. Pemberton, Marc M. Loriaux, Kristina Vartanian, Stephanie G. Willis, Gregory Yochum, Beth Wilmot, Yaron Turpaz, Raji Pillai, Brian J. Druker, Jennifer L. Snead, Mary MacPartlin, Stephen G. O'Brien, Junia V. Melo, Thoralf Lange, Christina A. Harrington, Michael W. N. Deininger
Journal: Blood
Blood (2010) 115 (2): 315–325.
https://doi.org/10.1182/blood-2009-03-210732
Published: 2010
Includes: Supplemental data
Journal Articles

A Gene Expression Signature of CD34+ Cells to Predict Major Cytogenetic Response in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Imatinib: Potential Involvement of Beta-Catenin in Drug Resistance.

Shannon McWeeney, Gregory Yochum, Lucy C. Pemberton, MD, FRCPath, Marc Loriaux, MD, PhD, Kristina Vartanian, Stephanie G Willis, Beth Wilmot, Yaron Turpaz, Raji Pillai, Mary Mac partlin, Jennifer Snead, PhD, Brian J. Druker, MD, Stephen G O'Brien, MD, PhD, Junia V. Melo, MD, PhD, Thoralf Lange, MD, Christina Harrington, Michael Deininger, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 508.
https://doi.org/10.1182/blood.V114.22.508.508
Published: 2009
Journal Articles

A Transcriptomal Profile for Predicting Complete Cytogenetic Response (CCR) in Chronic Phase CML Patients Treated with Imatinib.

Shannon K. McWeeney, PhD, Lucy C. Pemberton, MD, Chris A. Harrington, PhD, Brian J. Druker, MD, Michael W. Deininger, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1007.
https://doi.org/10.1182/blood.V110.11.1007.1007
Published: 2007